Literature DB >> 17229738

SHP-2 regulates cell growth by controlling the mTOR/S6 kinase 1 pathway.

Christina I Zito1, Hui Qin, John Blenis, Anton M Bennett.   

Abstract

Cell growth (accumulation in cell mass) ensues through the promotion of macromolecular biosynthesis. S 6 ribosomal kinase 1 (S6K1), which is activated by the mammalian target of rapamycin, is critical for cell growth. The early events that control S6K1 signaling remain unclear. Here we show that SHP-2 suppresses S6K1 activity under conditions of growth factor deprivation. We show that under conditions of growth factor deprivation, S6K1 activity was increased in fibroblasts lacking functional SHP-2 and in cells where knock down of SHP-2 expression was established by small interference RNA. Consistent with these findings, fibroblasts lacking functional SHP-2 exhibited increased cell size as compared with wild type cells. Growth factor deprivation reduces cellular energy, and the energy-sensing 5'-AMP-activated protein kinase (AMPK) negatively regulates S6K1. We found that SHP-2 promoted AMPK activity under conditions of growth factor deprivation (low energy), suggesting that SHP-2 negatively regulates S6K1 via an AMPK-dependent pathway. These results implicate SHP-2 as an early mediator in the S6K1 signaling pathway to limit cell growth in low energy states.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229738     DOI: 10.1074/jbc.M608338200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Inhibition of protein translation as a novel mechanism for prostaglandin E2 regulation of cell functions.

Authors:  Katsuhide Okunishi; Angela J DeGraaf; Zbigniew Zasłona; Marc Peters-Golden
Journal:  FASEB J       Date:  2013-09-26       Impact factor: 5.191

2.  Mechanical activation of mammalian target of rapamycin pathway is required for cartilage development.

Authors:  Yingjie Guan; Xu Yang; Wentian Yang; Cherie Charbonneau; Qian Chen
Journal:  FASEB J       Date:  2014-07-02       Impact factor: 5.191

3.  Novel role for SHP-2 in nutrient-responsive control of S6 kinase 1 signaling.

Authors:  Fatih Mercan; Hojin Lee; Sivanagarani Kolli; Anton M Bennett
Journal:  Mol Cell Biol       Date:  2012-11-05       Impact factor: 4.272

4.  LEOPARD syndrome-associated SHP2 mutation confers leanness and protection from diet-induced obesity.

Authors:  Mylène Tajan; Aurélie Batut; Thomas Cadoudal; Simon Deleruyelle; Sophie Le Gonidec; Céline Saint Laurent; Maëlle Vomscheid; Estelle Wanecq; Karine Tréguer; Audrey De Rocca Serra-Nédélec; Claire Vinel; Marie-Adeline Marques; Joffrey Pozzo; Oksana Kunduzova; Jean-Pierre Salles; Maithé Tauber; Patrick Raynal; Hélène Cavé; Thomas Edouard; Philippe Valet; Armelle Yart
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-06       Impact factor: 11.205

5.  Absence of γ-sarcoglycan alters the response of p70S6 kinase to mechanical perturbation in murine skeletal muscle.

Authors:  Catherine Moorwood; Anastassios Philippou; Janelle Spinazzola; Benjamin Keyser; Edward J Macarak; Elisabeth R Barton
Journal:  Skelet Muscle       Date:  2014-07-01       Impact factor: 4.912

6.  CEACAM1-Mediated Inhibition of Virus Production.

Authors:  Alon Vitenshtein; Yiska Weisblum; Sebastian Hauka; Anne Halenius; Esther Oiknine-Djian; Pinchas Tsukerman; Yoav Bauman; Yotam Bar-On; Noam Stern-Ginossar; Jonatan Enk; Rona Ortenberg; Julie Tai; Gal Markel; Richard S Blumberg; Hartmut Hengel; Stipan Jonjic; Dana G Wolf; Heiko Adler; Robert Kammerer; Ofer Mandelboim
Journal:  Cell Rep       Date:  2016-06-02       Impact factor: 9.423

Review 7.  Therapeutic Targets of KRAS in Colorectal Cancer.

Authors:  Shafia Rahman; Shimon Garrel; Michael Gerber; Radhashree Maitra; Sanjay Goel
Journal:  Cancers (Basel)       Date:  2021-12-11       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.